Santus, Luisa http://orcid.org/0000-0002-5992-0771
Sopena-Rios, Maria
García-Pérez, Raquel
Lin, Aaron E. http://orcid.org/0000-0001-7400-4125
Adams, Gordon C. http://orcid.org/0000-0003-1940-9706
Barnes, Kayla G. http://orcid.org/0000-0002-8291-4388
Siddle, Katherine J. http://orcid.org/0000-0002-1799-7295
Wohl, Shirlee
Reverter, Ferran http://orcid.org/0000-0002-9489-3350
Rinn, John L. http://orcid.org/0000-0002-7231-7539
Bennett, Richard S.
Hensley, Lisa E.
Sabeti, Pardis C. http://orcid.org/0000-0002-9843-1890
Melé, Marta http://orcid.org/0000-0001-8874-6453
Article History
Received: 25 August 2022
Accepted: 19 June 2023
First Online: 30 June 2023
Competing interests
: SAB Biotherapeutics, Inc. provided the study materials from the study by Luke et al. None of the authors of this study has financial interest in SAB Biotherapeutics, Inc. company. P.C.S. is a co-founder of, shareholder in, and advisor to Sherlock Biosciences, Inc.; a board member of and shareholder in the Danaher Corporation; and a co-founder of and shareholder in Delve Bio. The other authors declare no competing interests.